basic antimicrobial pharmacology

51
Basic Antimicrobial Pharmacology Dr. Matthias Götte Department of Medical Microbiology & Immunology Faculty of Medicine & Dentistry University of Alberta Email: [email protected] Date: September 15, 2020

Upload: others

Post on 05-Dec-2021

10 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Basic Antimicrobial Pharmacology

Basic Antimicrobial Pharmacology

Dr. Matthias Götte

Department of Medical Microbiology & Immunology

Faculty of Medicine & Dentistry

University of Alberta

Email: [email protected]

Date: September 15, 2020

Page 2: Basic Antimicrobial Pharmacology

Presenter Disclosure

MG received funding from Gilead Sciences Inc.

for mechanistic studies on Remdesivir.

Lecture Title: Date:

Page 3: Basic Antimicrobial Pharmacology

Learning Objectives

Provide a basic understanding of structure and

mechanisms of antivirals and antibiotics

Provide a basic understanding of mechanisms

associated with antimicrobial resistance (AMR)

Discuss therapeutic approaches designed to

overcome AMR

Lecture Title: Date:

Page 4: Basic Antimicrobial Pharmacology

Alignment with Learning Outcomes

Complex contributing factors to antimicrobial use

and the emergence and spread of AMR: a

biochemical perspective

Lecture Title: Date:

Page 5: Basic Antimicrobial Pharmacology

MSc Chemistry

PhD Biochemistry

HIV/HCV Lab

2000-2014 Emerging Pathogens

2014 - present

Matthias Götte, PhD

Professor and Chair

Department of Medical

Microbiology & Immunology

University of Alberta

Page 6: Basic Antimicrobial Pharmacology

SOURCE: Bean et al., 2013.

Emerging Viruses

Page 7: Basic Antimicrobial Pharmacology

Ebola Outbreaks 2014 and 2018

Page 8: Basic Antimicrobial Pharmacology

The novel coronavirus SARS-CoV-2 (Severe Acute

Respiratory Syndrome Coronavirus 2) is the causative

agent of COVID-19, first reported in December 2019.

WHO declares in March 2020 a pandemic.

Page 9: Basic Antimicrobial Pharmacology

Emerging Bacteria

Page 10: Basic Antimicrobial Pharmacology

Microorganisms and Pathogens

https://ib.bioninja.com.au/

Page 11: Basic Antimicrobial Pharmacology

Human Immunodeficiency Virus (HIV)

Page 12: Basic Antimicrobial Pharmacology

The 10 Leading Causes of Death in the US (1950 – 2000)

Strauss & Strauss 2008

Page 13: Basic Antimicrobial Pharmacology

”Triple Therapy”

Strauss & Strauss 2008

Page 14: Basic Antimicrobial Pharmacology

Fingers

Palm

Thumb

Viral Polymerases are Good Targets for Antiviral Drugs

HIV-1 Reverse Transcriptase

Page 15: Basic Antimicrobial Pharmacology

Castro et al., 2009; Nature Structural Biology

How do they function?

Page 16: Basic Antimicrobial Pharmacology

https://www.researchgate.net/figure/Mechani

sm-of-antiviral-action-of-AZT

AZT: the 1st HIV drug

Page 17: Basic Antimicrobial Pharmacology

N

H

O

C

H

3

O

N

O

Ho

O

H

Thymidine

N

H

O

C

H

3

O

N

O

Ho

N

3

N

H

O

C

H

3

O

N

O

Ho

O

N

N

H

2

N

O

Ho

O

H

Cytidine

O

N

N

H

2

N

O

S

Ho

AZT d4T

3TC

Different Nucleoside Analogue RT Inhibitors (NRTIs)

PP PP

P P

P

H

A

B

P

P

P

OHP

Chain-termination

Page 18: Basic Antimicrobial Pharmacology

Resistance To Antiviral Drugs

Page 19: Basic Antimicrobial Pharmacology

HIV exists as a mixture of

billions of different particles in

infected patients.

Why?

HIV and other viruses are

sloppy and make mistakes

during replication.

Why is this important?

Some of these viruses are

resistant to antiviral drugs.

Page 20: Basic Antimicrobial Pharmacology

HIV Levels Before Treatment HIV Levels on Treatment

Selection of Resistant Viruses on

Treatment

Page 21: Basic Antimicrobial Pharmacology

Take Your Medication to Keep Drug Levels

Sufficiently High

Page 22: Basic Antimicrobial Pharmacology

Monotherapy Fails

Triple Therapy Works

“Orange drugs” don’t work against resistant variants.

All three drugs are more effective and suppress the

emergence of resistant variants. AND “white and yellow

drugs” still work against resistant variants.

Page 23: Basic Antimicrobial Pharmacology

Why is the drug not working anymore?

Resistant variants contain mutations

that change the interaction with the

drug.

Drug Binding

Site

Altered Pocket

Reduces Binding

Drug Drug

Page 24: Basic Antimicrobial Pharmacology

Approved Anti-HIV Drugs

Initiation of

Triple Therapy

Drug

Classes

1-2

3-4

5Switch to

Novel Drug

Classes if

Necessary

Monotherapy

Page 25: Basic Antimicrobial Pharmacology

SARS-CoV-2 and COVID-19

Page 26: Basic Antimicrobial Pharmacology

Life Cycle of

SARS-CoV-2:

Looking for

Potential

Targets

Eastman et al. 2020, ACS Cent Sci

Page 27: Basic Antimicrobial Pharmacology

Source: Gilead Sciences Inc. Warren et al, Nature, 2016

Discovery of Remdesivir (GS-5734)

Gilead library of

nucleosides and

nucleotides

Screening

(CDC)

Prodrug design

(Gilead)

Profiling

(USAMRIID,

CDC)GS-441524 GS-5734

(Remdesivir)

Page 28: Basic Antimicrobial Pharmacology

Intracellular Metabolic Pathway

GS-441524GS-5734

NucleotidaseSlow First

Phosphorylation

Hydrolase

Phosphoramidase Nucleotide

Kinases

Alanine-MetaboliteNucleotide

Monophosphate

Active Nucleotide

Triphosphate

Protide by-passes

rate limiting first

phosphorylation

Page 29: Basic Antimicrobial Pharmacology

Resistance to Remdesivir ?In Vitro Selection in the Mouse Hepatitis Virus

Agostini et al. 2018, mBio

Page 30: Basic Antimicrobial Pharmacology
Page 31: Basic Antimicrobial Pharmacology
Page 32: Basic Antimicrobial Pharmacology

Remdesivir is a “Delayed Cain-Terminator”

Steric Clash with S861 and Remdesivir

Page 33: Basic Antimicrobial Pharmacology
Page 34: Basic Antimicrobial Pharmacology

Antibiotics

Page 35: Basic Antimicrobial Pharmacology

Alexander Fleming discovered Penicillin in

1928 (Nobel Prize in 1945)

He noticed that bacteria do not

grow near fungus. Though this

experiment was not planned,

he discovered that the fungus

produces a “mold juice” later

referred to as penicillin…

Page 36: Basic Antimicrobial Pharmacology
Page 37: Basic Antimicrobial Pharmacology

Lactams Inhibit Cell Wall Synthesis

Page 38: Basic Antimicrobial Pharmacology

https://basicmedicalkey.com/chemotherapy-of-tuberculosis-mycobacterium-avium-complex-disease-and-leprosy/

Page 39: Basic Antimicrobial Pharmacology

Fleming and Antibiotic Resistance

Fleming discovered that bacteria

developed antibiotic resistance whenever too

little penicillin was used or when it was used for too

short a period.

He warned in 1945:

“The time may come when penicillin can be bought

by anyone in the shops. Then there is the danger

that the ignorant man may easily underdose himself

and by exposing his microbes to non-lethal quantities

of the drug make them resistant.”

Page 40: Basic Antimicrobial Pharmacology

https://www.gov.uk/.../health-matters-antimicrobial-resistance

UK Economist Jim O’Neill et al. 2014

Page 41: Basic Antimicrobial Pharmacology

https://www.gov.uk/.../health-matters-antimicrobial-resistance

Page 42: Basic Antimicrobial Pharmacology

https://www.canada.ca…preserving-antibiotics/about-antibiotic-

resistance.html

Page 43: Basic Antimicrobial Pharmacology

From AMR Spread between Bacteria…

Barton et al. 2007. Evolution.

Page 44: Basic Antimicrobial Pharmacology

https://www.reactgroup.org

Mechanisms of Antibiotic Resistance

Page 45: Basic Antimicrobial Pharmacology

Focus on Inactivating Enzymes

Beta-Lactamase

Enzymes

Page 46: Basic Antimicrobial Pharmacology

Alternative Treatments: Phage Therapy

Phages Are Viruses that Infect Bacteria

Salmond, G. P. & Fineran, P. C.

Nat. Rev. Microbiol. 13,777–786

(2015).

Page 47: Basic Antimicrobial Pharmacology

1Department of Biological Sciences, University of Pittsburgh,

Pittsburgh, PA, USA. 2Great Ormond Street Hospital, London, UK.

3Department of Medicine,

University of California, San Diego, La Jolla, CA, USA. 4These authors

contributed equally: Rebekah M. Dedrick and Carlos A. Guerrero-

Bustamante.

*e-mail: [email protected]; [email protected]

Nature Medicine | 730 VOL 25 | MAY 2019 | 730–733 |

www.nature.com/naturemedicine

Page 48: Basic Antimicrobial Pharmacology

A 15-year-old patient with cystic fibrosis and a life-threatening bacterial

infection was treated with a three-phage cocktail following lung

transplantation. Lytic phage derivatives efficiently killed the infectious.

Phage treatment was associated with clinical improvement, although the

athors cannot exclude the possibility that patient gains would have occurred

without phage treatment.

Triple Therapy Killed Antibiotic Resistant Bacteria

Page 49: Basic Antimicrobial Pharmacology

Summary

Nucleoside analogues are frequently used antivirals

These compounds target the viral polymerase and

interfere with genome replication

Resistance is selected from a pool of diverse viruses

Lactams are frequently used antibiotics

These compounds interfere with cell wall synthesis

Selection of resistance in bacteria is often based on similar

principles as reported for viruses

Lecture Title: Date:

Page 50: Basic Antimicrobial Pharmacology

Discussion Questions

Describe important principles underlying the selection of resistance

in viruses and bacteria, respectively.

What is a fundamentally different mechanism that is used by

Bacteria?

Non-adherence to antimicrobial drug regimens can lead to the

development of resistance. Why?

A combination of antivirals or antibiotics can prevent the

emergence of resistance. Why?

Lecture Title: Date:

Page 51: Basic Antimicrobial Pharmacology

Thank You!

Dr. Matthias Götte

Department of Medical Microbiology &

Immunology

Faculty of Medicine & Dentistry

University of Alberta

Email: [email protected]

Lecture Title: Date: